Roche plans to take its latest Alzheimer's drug attempt to Phase 3

Roche on Thursday shared early positive results for its Alzheimer’s candidate trontinemab, the latest round of data in its second attempt to develop a drug for the disease. The company said it's planning for a ...

Apr 3, 2025 - 17:19
 0
Roche plans to take its latest Alzheimer's drug attempt to Phase 3
Roche on Thursday shared early positive results for its Alzheimer’s candidate trontinemab, the latest round of data in its second attempt to develop a drug for the disease. The company said it's planning for a ...